KARO PHARMA AB COMPLETES VOLUNTARY OFFER FOR WEIFA ASA
· Karo Pharma AB ("Karo Pharma") has today successfully completed the voluntary offer for Weifa ASA ("Weifa"). Payment of the offer price is being made today to the Weifa shareholders who accepted the voluntary offer and the cash consideration will be available on such shareholders' registered bank accounts in the VPS on or around 9 October 2017. At the same time, 35,453,352 tendered shares are being transferred to Karo Pharma. As a result, Karo Pharma now holds 97.21% of the shares and voting rights in Weifa. · Karo Pharma intends to effect a compulsory acquisition of the remaining